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INTRODUCTION 
Serum lipid concentrations have been studied in different
psychiatric disorders. Low concentrations of cholesterol and
lipoproteins have been found in patients with schizophrenia
(1, 2), antisocial personality (3), borderline personality disorder,
suicidal (4) or aggressive behavior (5, 7), as well as in popu-
lation with criminal past (8). Studies provided on patients with
major depressive disorder (MDD) showed contradictory results
because some of them showed low cholesterol concentrations
(9, 10) while others did not find any lipid concentration cha-
nges (11, 12). In patients with manic or mixed manic episodes
high concentrations of cholesterol have been found (13). In
studies on patients with anxiety disorders such as panic dis-
order (14, 15), generalized anxiety disorder (16, 17), obsessive-
compulsive disorder (18) and post-traumatic stress disorder
(PTSD) (19, 20) increased concentrations of serum lipids have
been found. However, epidemiological as well as clinical stud-
ies have shown that PTSD often occurs with other psychiatric
disturbances (21). Those studies indicated that approximately
80% of individuals with PTSD met criteria for at least one
additional psychiatric diagnosis. The MDD is one of the most
frequent comorbid condition with PTSD and prevalence of
MDD in patients with PTSD is expressed up to 70% (22). 
Our hypothesis was that in veterans with PTSD comorbid
with MDD serum lipids concentrations is lower than in vet-
erans with PTSD only, or in other words they have similar
lipids concentrations like veterans with MDD or healthy con-
trol subjects.
The aim of this study was to analyze the concentrations of
serum cholesterol, low-density lipoprotein cholesterol (LDL-C),
high-density lipoprotein cholesterol (HDL-C), triglycerides,
and to assess the LDL-C/HDL-C ratio in Croatian veterans
with combat-related chronic PTSD opposite to war veterans
with combat-related chronic PTSD comorbid with MDD,
war veterans with MDD and healthy control group. 
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Serum Lipid Concentrations in Croatian Veterans with Post-traumatic
Stress Disorder, Post-traumatic Stress Disorder Comorbid with Major
Depressive Disorder, or Major Depressive Disorder
The aim of this study was to assess eventual differences in serum cholesterol, low-
density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-
C), triglycerides, LDL-C/HDL-C ratio between veterans with combat-related post-
traumatic stress disorder (PTSD) only or comorbid with major depressive disorder
(MDD), veterans with combat experiences with MDD, and healthy control group.
PTSD and/ or MDD were diagnose according to structured clinical interview based
on DSM-IV criteria. Additional criteria to diagnose PTSD were Clinician Administered
PTSD Scale (CAPS), and to diagnose MDD Montgomery-Asberg Depression Rat-
ing Scale (MADRAS). Serum lipid concentrations were determined by using the
enzyme-assay method. Veterans with combat-related PTSD as well as veterans
with combat-related PTSD comorbid with MDD showed significantly higher concen-
trations of cholesterol (F=9.858, p<0.01), triglycerides (F=10.112, p<0.01), LDL-C
(F=11.145, p<0.01), and LDL-C/HDL-C ratio (F=8.346, p<0.01) vs. veterans with
MDD or healthy control group. Contrary healthy control group and veterans with
MDD showed significantly higher concentrations of HDL-C (F=8.421, p<0.01), vs.
veterans with PTSD or PTSD comorbid with MDD. In conclusion, there are no dif-
ferences in serum lipid concentrations between veterans with combat-related PTSD
and PTSD comorbid with MDD, but they have higher lipid concentrations than vet-
erans with MDD or healthy control subjects. 
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MATERIALS AND METHODS
Subjects
The first study group consisted of 43 male veterans with
chronic combat-related PTSD, aged between 26 and 47 yr.
The duration of their combat activity ranged from 1 to 4 yr.
The number of their combat traumas ranged from 2-5. Time
elapsed since they had experienced combat traumas ranged
from 6 to 10 yr. The second study group consisted of 37 male
veterans with chronic combat-related PTSD comorbid with
MDD, aged between 25 and 45 yr. The duration of their com-
bat activity ranged from 1 to 4 yr. The number of their com-
bat traumas ranged from 1-5. Time elapsed since they had
experienced combat traumas ranged 6 to 10 yr. The third
study group consisted of 38 male veterans with MDD, aged
between 25 and 46 yr. The duration of their combat activity
ranged from 1 to 4 yr. The number of their combat traumas
ranged from 2-4. Time elapsed since they had experienced
combat traumas ranged from 6 to 10 yr. Subjects from all
study groups, when they had been drafted for active military
service, they went through rigorous entrance tests, which
ensured that they had not had any previous major psychiatric
or somatic disorders. All investigated patients did not have
any other psychiatric comorbid disorders or medical problems,
and took different medications in medical history prior to this
study, mostly antidepressants (fluoxetine 8.9%, fluvoxamine
5.2%, paroxetine 25.4%, sertraline 27%, clomipramine
18.7%, trazadone 1.4%, and maprotiline 13.4%) and anxi-
olytics (alprazolam 18.7%, oxazepam 8.6%, diazepam 57.6%,
clonazepam 15.1%). 75% of the patients sometimes took
some hypnotics during therapy (nitrazepam, funitrazepam
or zolpidem). None of the above mentioned drugs influence
serum lipids concentrations (23). The control group consisted
of 39 healthy men, mostly our hospital workers, aged 28-47
yr. They had negative anamnesis data of alcohol or other drugs
of dependence abuse. Informed consent was obtained from
patients and controls after complete and extensive description
of the study profile. 
Because lipid concentration are sensitive to even relatively
subtle psychosocial influences, our experience has indicated
that it is important to describe these factors in some details,
which characterize PTSD patients as well as the control group.
Descriptive parameters of all included subjects are presented
in Table 1. Almost half of the subjects were married (65.1%
in PTSD, 48.6% in PTSD comorbid with MDD, 60.5% in
MDD and 58.3% in the control group). Most of the subjects
had secondary schooling (74.4% in PTSD, 62.2% in PTSD
comorbid with MDD, 68.4% in MDD, and 71.8% in control
group). Most of them lived in urban areas (60.5% in PTSD,
56.8% in PTSD comorbid with MDD, 60.5% in MDD, and
69.4% in control group). Subjects with PTSD, PTSD comor-
bid with MDD, or MDD were in inpatient hospital treatment.
During hospitalization, they undertook an intensive schedule
of 30 hr of individual and group therapy per week, as well
as other socio-therapeutic activities. Treatment program was
based on the therapeutic community (24).
Medical examination and study design
From the pool of all male patients (n=891) who were receiv-
ing treatment in the University Department of Psychiatry in
‘‘Sestre milosrdnice’’ University Hospital in 2001 and 2002,
we elected three study groups; patients with combat-related
PTSD only (n=43) or comorbid with MDD (n=37), and pa-
tients with combat-experiences with MDD only (n=38). Pa-
tients with other psychiatric disorders (n=673), and comorbid
psychiatric disorders in PTSD group (n=63), (except MDD
in PTSD group) or somatic conditions (n=28) were excluded
from the study in all study groups. Also because the patients
did not give informed consent we excluded them from the
study (2 in PTSD group, 3 in PTSD comorbid with MDD
group, and 4 in MDD group).
A psychiatrist performed the structured clinical interview
and made diagnosis based on DSM-IV criteria for PTSD or/
and MDD (25). Clinical psychologist applied Clinician Ad-
ministered PTSD Scale (CAPS) PTSD interview based on
DSM-IV criteria to measure post-traumatic stress reaction
(26). Final diagnosis of PTSD was reached only in cases where
both sets of criteria were fulfilled. Diagnostic agreement be-
tween psychiatric and psychological criteria was high  =0.96.
The alpha coefficient for the CAPS questionnaire in our study
was 0.91. We accepted the diagnosis of MDD if the patients
fulfilled two criteria: indicative result on the Montgomery-
Asberg Depression Rating Scale (MADRAS) (27) and suffi-
cient number of symptoms shown in the structural clinical
interview based on DSM-IV criteria for MDD (25). Diagnos-
tic balance between the MADRAS and clinical interview based
on DSM-IV criteria for MDD was  =0.98. MADRAS ques-
Characteristics
PTSD
(n=43)
PTSD+MDD
(n=37)
MDD
(n=38)
Control group
(n=39)
Age (yr), (mean±SD)* 41.3±8.3 42.9±7.3 46.2±11.3 43.8±10.1
Marital status, No. (%)
�
Married 28 (65.1) 18 (48.6) 23 (60.5) 23 (58.3)
Unmarried/divorced/ 15 (34.9) 19 (51.4) 15 (39.5) 16 (41.7)
widower
Education, No. (%)
�
Elementary school 6 (14.0) 8 (21.6) 3 (17.9) 5 (13.9)
High school 32 (74.4) 23 (62.2) 26 (68.4) 22 (61.1)
University education 5 (11.6) 6 (16.2) 9 (23.7) 9 (25.0)
Living place, No. (%)
�
Urban 26 (60.5) 21 (56.8) 23 (60.5) 25 (69.4)
Village 17 (39.5) 16 (43.2) 15 (39.5) 11 (30.6)
Table 1. Sociodemographic characteristic of the veterans with
post-traumatic stress disorder (PTSD), PTSD comorbid with major
depressive disorder (MDD), MDD, and control healthy group
*F=1.939, p=0.126; 
� 2=2.318, p=0.509; 
� 2=5.691, p=0.459; 
� 2=1.346,
p=0.718.tionnaire was used because of its simplicity and reliability, in
our study alpha coefficient was 0.93. Two psychiatrists per-
formed this part of the evaluation, each of them examining
independently all the subjects. The agreement between two
psychiatrists was high,  =0.97. 
We also compared PTSD group and MDD group accord-
ing to DSM IV criteria for nicotine dependence (25) because
smoking has a strong effect on elevation of serum lipids (28).
And last, body mass index (BMI) was calculated for PTSP
and MDD group because BMI correlated well with serum
lipids level (28). BMI is ratio representing each patients weight
in kilograms divided by square of height in meters (BMI=
kg/m2). Since diet and activity can influence the results of
examinations, laboratory measures and psychiatric examina-
tions were carried out between days 14 and 16 of inpatient
stay. Blood lipids measurements at this time may be prefer-
able to values on admission to ensure that all patients had
equivalent diets and activity levels. 
Biochemical measurements
Blood samples were collected from forearm vein, in glass
red-topped, vacuum tubes without any anticoagulant, in the
morning between 8-9 a.m., after overnight fast of 12 hr and
30 min resting immediately prior to blood collection. Serum
concentrations for cholesterol, HDL, and triglyceride were
measured by enzyme assay (EA), immediately after taking the
samples with commercial kits (Olympus Diagnostic, GmbH,
Hamburg, Germany) on Olympus AU 600 automatic ana-
lyzator. The interassay coefficient of variation in our labora-
tory was 3.2% for cholesterol, 2.5% for triglycerides, and
3.0% for HDL-C. Serum LDL-C concentrations were calcu-
lated by following formula: LDL-C=cholesterol-(HDL-C -
tryglicerides/5)] (29). Our laboratory’s referent intervals for
lipids are parameters measured as follow: cholesterol 147-220
mg/dL, LDL lower than 150.0 mg/dL, HDL higher than 42.0
mg/dL, LDL-C/HDL-C ratio lower than 130.0, and triglyc-
eride 53-177 mg/dL.
Statistical analyses
We use chi-quadrate test to analyze difference in nicotine
dependence or sociodemographic variables between four gr-
oups. The normal distribution was assessed for all measures
and for each group by Kolmogorov-Smirnov test. Subjects
with PTSD, subjects with PTSD comorbid with MDD, sub-
jects with MDD, and control group (except in war variables
for control group) were compared in age, blood glucose con-
centration, systolic or diastolic blood pressure, duration of
combat activity, duration of PTSD symptoms, and number
of combat traumas by analysis of variance (ANOVA) and
Scheffe’s post-hoc analysis for pair-wise comparisons. Analy-
sis of covariance (ANCOVA) with age, BMI, blood glucose
concentrations, diastolic or systolic blood pressure as a covari-
ates, was used to analyze differences in serum cholesterol,
triglycerides, LDL-C, HDL-C, and LDL-C/HDL-C ratio in
subjects with PTSD, subjects with PTSD comorbid with
MDD, subjects with MDD, and control group. Age, BMI,
blood glucose concentrations, diastolic or systolic blood pres-
sure was used as covariates because that variable can influence
serum lipid concentrations (28). 
A p value of <0.01 was considered to denote the presence
of a statistically significant difference. Statistics was done with
SPSS software (SPSS for Windows 8.0, SPSS, Chicago, IL,
U.S.A.).
RESULTS
There was no statistically significant difference in age be-
tween veterans with combat-related chronic PTSD, combat-
related chronic PTSD comorbid with MDD, MDD, and con-
trol group, as well as in marital status, education, and living
place (Table 1). Regarding combat activity duration, num-
ber of combat traumas as well as duration of PTSD symptoms
and/or MDD, there was no statistically significant difference
between veterans with combat-related PTSD, veterans with
combat-related PTSD comorbid with MDD, veterans with
MDD, and healthy control group (Table 2).
DSM-IV criteria for nicotine dependence were met by
74.4% of veterans with combat-related PTSD and 83.8% of
veterans with PTSD comorbid with MDD, 65.8% of veterans
with MDD, and 72.2% of healthy control subjects ( 2=3.237,
p=0.356). There was no statistically significant difference in
BMI, blood glucose concentrations, systolic or diastolic blood
pressure between veterans with combat-related chronic PTSD,
combat-related chronic PTSD comorbid with MDD, MDD,
and control group (Table 3).
Veterans with combat-related PTSD as well as veterans
with PTSD comorbid with MDD showed significantly higher
cholesterol, LDL-C, LDL-C/HDL-C ratio, and triglyceride
concentrations compared to veterans with combat-experiences
with MDD and healthy control group (Table 4). HDL-C was
statistically significantly lower in veterans with combat-related
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Variable*
PTSD
(n=43)
PTSD+MDD
(n=37)
MDD
(n=38)
F-value p-value
Duration of combat  2.4±0.9 2.2±1.0 2.3±0.8 0.475 0.700
activity, years
Duration of symptoms, 6.5±0.8 6.8±1.0 6.6±0.9 0.204 0.894
years 
Number of combat  2.5±0.8 2.6±1.1 2.4±0.8 0.475 0.721
traumas
Table 2. Duration of combat activity, duration of symptoms, and
number of combat traumas in veterans with post-traumatic stress
disorder (PTSD), PTSD with comorbid major depressive disorder
(MDD), and MDD
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PTSD and veterans with PTSD comorbid with MDD opposite
to veterans with MDD or healthy control group (Table 4).
DISCUSSION
Our results showed higher concentrations of cholesterol and
triglycerides in veterans with combat-related chronic PTSD
as well as in veterans with combat-related PTSD comorbid
with MDD opposite to veterans with only MDD or healthy
control group. Also our results show a very high risk of devel-
oping arteriosclerosis in veterans with combat-related PTSD
only or comorbid with MDD contrary to veterans with MDD
or healthy control group. The reason is the low level of HDL-
C, high level of LDL-C, and high LDL-C/HDL-C ratio.
These findings are in accordance with the results of the
investigation on Vietnam or Croatian veterans with chronic
PTSD (19, 20). However, the research on Vietnam veterans
did not include the analysis of the LDL-C and HDL-C. Also
this study contrary to prior study provided on Croatian war
veterans in which control group was formed of patients with
MDD, included, veterans with combat-experiences with
MDD as well as healthy control subjects. Our opinion is that
it was necessary because some researchers pointed out that
MDD is associated with low serum lipids concentrations (9,
10). Because of those findings our hypothesis was that in vet-
erans with PTSD comorbid with MDD serum lipids concen-
trations is lower than in veterans with PTSD only, or in other
words they have similar lipids concentrations like veterans
with MDD or healthy control subjects. However, our results
are opposite to our expectations, and further more our results
are contrary to the results of the studies which find low serum
lipids concentrations in patients with MDD. The explanation
for those differences maybe lies in cross-cultural differences
in diet habit, sample size, or in rigorous diagnostic criteria
that were used for subject inclusion in our study contrary than
others. 
Our study has several limitations, also. For example we do
not compare our subjects in diet anamnesis data. Also we com-
pared only war veterans with PTSD only or comorbid with
MDD with veterans with MDD and healthy control subjects.
In future research it will be interesting to explore serum lipid
concentrations in civil subjects with PTSD. And the third
limitation is in male gender of our subjects in all four groups
because male gender is connected with higher cholesterol,
triglycerides, and LDL-C as well as low HDL-C concentra-
tions than female. 
However, former research on the patients with PTSD show-
ed many biological alterations such as hypersensitivity of
steroid receptors (30), and alterations in hypothalamic-pitu-
itary-adrenal/thyroid axis (31). In interpretation of our results,
it is important to note the findings that focused on high con-
centration of catecholamines (32), and an increase of sympa-
thetic nerve system activity, which manifested itself through
an intensified heartbeat and blood pressure (33, 34). There-
fore, the drugs that increase the activity of noradrenergic sys-
tem can induce symptomatology of PTSD (35). On the other
hand, in large investigation of patients with arterial hyper-
tension and other risk factors for developing arteriosclerosis,
researchers found increased activity of noradrenergic system,
*(mean±SD),
� ANOVA.
Lipids variable*
PTSD
(n=38)
PTSD+MDD
(n=37)
MDD
(n=38)
Control group
(n=39)
F-value
� p-value
BMI 24.9±2.1 24.8±1.9 23.9±2.3 23.7±1.8 0.979 0.405
Blood glucose (mg/dL) 98.6±16.2 99.1±18.9 95.4±23.4 93.6±16.0 1.197 0.313
Systolic pressure (mmHg) 128.6±12.8 125.1±11.5 129.5±13.1 124.8±12.2 1.856 0.140
Diastolic pressure (mmHg) 83.9±6.9 84.1±7.2 83.2±7.9 85.1±6.3 0.435 0.728
Table 3. Body mass index (BMI), blood glucose concentrations, systolic blood pressure, and diastolic blood pressure in veterans with
post-traumatic stress disorder (PTSD), PTSD comorbid with major depressive disorder (MDD), MDD, and in healthy control group
*(mean±SD), 
�
significantly different from the MDD and control group (post-hoc Scheffe testing, <0.01), 
�
ANCOVA (after adjusted for BMI, ages, blood
glucose concentrations, systolic and diastolic blood pressure as covariates).
Lipids variable*
PTSD
(n=38)
PTSD+MDD
(n=37)
MDD
(n=38)
Control group
(n=39)
F-value
� p-value
Cholesterol (mg/dL) 239.9±46.4
� 243.8±50.3
� 197.4±38.7 205.1±42.5 11.016 <0.01
Triglycerides (mg/dL) 203.5±123.9
� 194.7±106.2
� 115.1±53.1 123.9±61.9 10.365 <0.01
LDL-C (mg/dL) 157.5±33.7
� 161.2±33.7
� 135.1±26.2 123.7±30.1 11.676 <0.01
HDL-C (mg/dL) 38.6±11.2
� 42.5±10.3
� 50.3±12.9 54.1±11.6 9.528 <0.01
LDL-C/HDL-C ratio 134.5±42.6
� 137.7±49.2
� 104.9±32.8 98.4±30.1 8.346 <0.01
Table 4. Concentrations of serum cholesterol, triglycerides, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein choles-
terol (HDL-C), triglycerides, in veterans with post-traumatic stress disorder (PTSD), PTSD comorbid with major depressive disorder
(MDD), MDD, and in healthy control groupLipids in PTSD or PTSD Comorbid with MDD 435
and a correlation between the increased levels of cholesterol
and catecholamines (36, 37). In these studies researchers point-
ed out that norepinephrine increase the activity of lipoprotein
lipase, and the result of increased activity of lipoprotein lipase
is increase of free fatty acids in the serum, which in turn may
be converted by the liver into cholesterol. Furthermore, in one
study provided on patients with panic disorder authors was
found correlation between increased activity of lipoprotein
lipase, cholesterol, and catecholamines concentrations (14).
In conclusion, we can say that high levels of serum lipids
in PTSD are probably the consequence of the increased activity
of the noradrenergic system, because there is strong correla-
tion between noradrenalin and lipids level (36, 37). Therefore,
the population with PTSD is at risk of numerous somatic com-
plications, especially cerebro/cardio-vascular disorders, because,
the increase of serum lipids is directly related to the higher
risk of arteriosclerosis and vascular incidents (38). The new
research should investigate the correlation between the PTSD,
the level of the serum lipids, and concentration of catechola-
mines. Also, in the future routine serum lipids screening in
of patients with PTSD is necessary as well as undertaking pre-
ventive actions for decrease of atherosclerosis with all conse-
quences in patients with PTSD.
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